OncoSec Medical Aktie

https://www.analystratings.com/articles/btig-maintains-their-buy-rating-on-oncosec-medical-oncs/

OncoSec Medical Announces FINRA Approval of Reverse Stock Split Print Alert OncoSec Medical Incorporated (USOTC:ONCSD) Historical Stock Chart 1 Month : From Apr 2015 to May 2015 SAN DIEGO, May 15, 2015 /PRNewswire/ -- OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Financial Industry Regulatory Authority ("FINRA") has approved the company's 1-for-20 reverse stock split. According to FINRA's approval, the reverse stock split will become effective and OncoSec's common stock will begin trading on a post-split basis before the open of trading on May 18, 2015.

    PR NEWSWIRE 1:09 PM ET 5/27/2015  SAN DIEGO , May 27, 2015 /PRNewswire/ -- OncoSec Medical Inc. ("OncoSec") , a company developing DNA-based intratumoral cancer immunotherapies, today announced the company has received approval to begin trading its common stock on The NASDAQ Stock Market LLC. OncoSec's common stock will begin trading on The NASDAQ Stock Market LLC at the opening of market hours on Friday, May 29.  "Over the past year, our team has made significant headway to build a strong, cutting-edge, clinical stage biotech company. As we become a NASDAQ-listed company, we are now able to communicate our progress with a broader audience, raise the visibility of OncoSec's capabilities, and generate more value for our shareholders," said Punit Dhillon, President and CEO of OncoSec. "We are now in a better position to continue to advance our intratumoral immunotherapy technologies with the goal of one day benefiting cancer patients everywhere." 

bin gespannt wie die amis reagieren http://www.businesswire.com/news/home/20150218005271/en/OncoSec-Medical-Heat-Biologics-Announce-Collaboration-Evaluate#.VORzUC7adGE